NCT07486518

A Multicentre Observational Cross-Sectional Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India

RecruitingOBSERVATIONAL

Trial Details

Start: 2026-08-01Est. Completion: 2028-04-01

Enrollment target: 4,000 participants

Locations

AIG Hospitals, Hyderabad, Telangana, India

Contact

Dr.Hardik Rughwani Dr.Hardik Rughwani, MBBS, MD, DMhardik.hr@gmail.com +91-9426928600

Other microbiome trials you might be interested in

Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric AdenocarcinomaPhase 2Recruiting

Esophageal CancerGastric (Stomach) CancerGastric AdenocarcinomaGastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaEsophageal CarcinomaGastric (Cardia, Body) Cancer

Purpose of the Study: This clinical study investigates whether a shorter or longer duration of systemic therapy before …

Amsterdam, NetherlandsEst. completion Nov 2031

View Trial →

Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer.Phase 3TERMINATED

Gastric Cancer

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.